WLA Health & Care AG has launched an equine inhalation system built on the vibrating mesh technology of leading Irish medical technology company, Aerogen®.
WLA Health & Care AG has launched the BIBO Pulmifier® Equine, an equine inhalation system built on the vibrating mesh technology of Aerogen®, with whom WLA has signed a strategic partnership. Aerogen® is the world leader in acute care aerosol drug delivery with over 25 years of experience. This gives horse owners, riders, and stable professionals an equine inhalation device built with core technology used in human medicine, where reliability and consistent performance are mandatory.
Healthy airways are essential for every horse, from leisure partners to elite sport horses. Owners who frequently deploy equine inhalation need a device that delivers the same performance, day after day. That is exactly what the BIBO Pulmifier® Equine was designed for: delivering up to 2,000 doses that perform consistently with every use.
Critical-care technology for everyday stable life
Vibrating mesh technology uses precision-made mesh that vibrates at a very high frequency, to turn liquid medication into an aerosol. Within hospital settings, Aerogen® has established its products and technology as the standard in acute and critical intensive care. With the BIBO Pulmifier® Equine, the proven efficacy and reliability are now available in the stable.
A deliberate decision by Aerogen®
The launch is borne out of a strategic partnership between WLA Health & Care AG and Aerogen®. WLA Health believed that Aerogen’s vibrating mesh technology could set a new standard in animal health, having already supported over 30 million respiratory patients in 80 countries. The result is the BIBO Pulmifier® Equine, the new standard for equine inhalation in Europe.
Armin Probst, CEO of WLA Health & Care AG: “For many years, I worked towards making a technology available to horses that is as reliable as human medicine. Seeing this become a reality makes me incredibly proud. The collaboration with Aerogen® – a proven leader in aerosol drug delivery – has made this product a reality. For me, it is the fulfilment of a long-held goal.”
Patrick Power, Vice President Business Development & Corporate Strategy at Aerogen® and Co-Chief Executive of WLA Health & Care AG: “Aerogen’s vibrating mesh technology has proven its efficacy in over 30 million respiratory patients. This strategic partnership brings that technology from human healthcare into equine care. But taking our technology into a new field is not just a question of engineering. You need people with a unique understanding of the sector. In WLA Health & Care AG, we found the right partner and look forward to delivering the future of equine inhalation care together.”
Availability
From 15 October 2026, the BIBO Pulmifier® Equine is available across Europe via www.bibo-pulmifier.com
BIBO Pulmifier® Equine at a glance
Vibrating Mesh Nebuliser (VMN) – BIBO Pulmifier® powered by Aerogen® technology
One nebuliser delivers up to 2,000 doses¹ – with daily dosing, this represents around five years without device-specific follow-up costs
Aerosol: volume median diameter (VMD) 3.5 µm, 73.3% of droplets between 1 and 5 µm
Connect the nebuliser to the controller, connect the controller to the mask, start dosing
Cordless: battery-powered, no external power source or connecting cable
Controller rated IP44 – protected against solid objects of 1 mm or larger and against splashing water from any direction
Mask with integrated aerosol chamber for targeted delivery directly into the nostrils, developed with veterinarians
Two mask options: Cordura® SoftFit (skin-friendly, OEKO-TEX® STANDARD 100) for training and everyday stable use; PE PureFit with antibacterial additive², easy to clean, also suitable as a competition mask
Made in Ireland and Germany
About WLA Health & Care AG
WLA Health & Care AG, based in Kreuzlingen, Switzerland, develops solutions for animal health, well-founded, carefully considered, and with scientific rigour. The name says it all: WLA stands for “We love animals." The company combines hands-on knowledge from the stable with technology from human medicine and works with international specialists and research institutions. Development and production take place in the EU and Switzerland to strict quality standards. New products are developed only where they solve a real problem – across species, indications, and disciplines. Its core product is the BIBO Pulmifier® Equine, an equine inhalation system with vibrating mesh technology from Aerogen®. WLA is part of the Stamford Devices Limited Group of companies. More information: wla-health.com
